Prospective case-control study on neuropsychological testing before and after therapeutic-diagnostic cerebrospinal fluid puncture in patients with idiopathic intracranial hypertensio

Not Applicable

• Conditions: G93.2; Benign intracranial hypertension

• Registration Number: DRKS00033278
• Lead Sponsor: MU Klinikum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-12-01
• Study Start: 2024-01-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Diagnosis of idiopathic intracranial hypertension according to the criteria of IHS III beta
- Signed informed consent form
- Patient age between 18-70 years
- Stable medication for at least one week and no intake of centrally acting medication immediately prior to testing

Exclusion Criteria

- Concomitant pre-existing illness that could also have an impact on cognitive performance, in particular organically detectable cognitive deficits (e.g. dementia)
- Medical contraindications with regard to a cerebrospinal fluid puncture
- Severe internal or psychiatric illness
- Acute drug or substance abuse
- Lack of ability (e.g. impaired vision) and motivation for testing

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Differences in neurocognitive test batteries between patients and controls

Secondary Outcome Measures

Name	Time	Method
Differences in neurocognitive test batteries before and after lumbar puncture of patients